Literature DB >> 24039307

Design and synthesis of 3,5-disubstituted boron-containing 1,2,4-oxadiazoles as potential combretastatin A-4 (CA-4) analogs.

Bhaskar C Das1, Xiang-Ying Tang, Patrick Rogler, Todd Evans.   

Abstract

We have designed and synthesized a small library of 3,5-disubstituted-1,2,4-oxadiazole containing combretastatin A-4 (CA-4) analogs. Our objective is to increase the efficacy of the CA-4 as an anti-tubulin and antimitotic agent by substituting the cis-alkene bond with one of its bioisosteres, the 1,2,4-oxadiazole ring. We also modified the substituents attached to both of the phenyl rings (ring A and B in Fig. 1) of CA-4 for the purpose of diversifying our analogs based on SAR. These compounds were synthesized via a coupling reaction between an amidoxime and a carboxylic acid in DMF solvent, with HOBt as a base, and utilizing EDCI as a coupling reagent. Using this protocol, we synthesized a small library of 10 compounds with moderate to good yields. A detailed biological study is currently undergoing in our laboratory to evaluate the activity of these compounds.

Entities:  

Keywords:  3,5-Disubstituted 1,2,4-oxadiazole; Bioisosteres; Boron-containing CA4 compound; Combretastatin A-4; Tubulin; Vascular disrupting agent

Year:  2012        PMID: 24039307      PMCID: PMC3771381          DOI: 10.1016/j.tetlet.2012.02.110

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  36 in total

1.  Structural requirements for the interaction of combretastatins with tubulin: how important is the trimethoxy unit?

Authors:  Keira Gaukroger; John A Hadfield; Nicholas J Lawrence; Steven Nolan; Alan T McGown
Journal:  Org Biomol Chem       Date:  2003-09-07       Impact factor: 3.876

2.  The new era of 1,2,4-oxadiazoles.

Authors:  Andrea Pace; Paola Pierro
Journal:  Org Biomol Chem       Date:  2009-09-16       Impact factor: 3.876

3.  Synthesis of novel 1,3,4-oxadiazole derivatives as potential antimicrobial agents.

Authors:  Rakesh Chawla; Anshu Arora; Manoj Kumar Parameswaran; Prabodh Chan; Der Sharma; Sukumar Michael; Thengungal Kochupappy Ravi
Journal:  Acta Pol Pharm       Date:  2010 May-Jun       Impact factor: 0.330

4.  Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).

Authors:  George R Pettit; Mathew D Minardi; Heidi J Rosenberg; Ernest Hamel; Michael C Bibby; Sandie W Martin; M Katherine Jung; Robin K Pettit; Timothy J Cuthbertson; Jean-Charles Chapuis
Journal:  J Nat Prod       Date:  2005-10       Impact factor: 4.050

Review 5.  Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer.

Authors:  Philippe L Bedard; Angelo Di Leo; Martine J Piccart-Gebhart
Journal:  Nat Rev Clin Oncol       Date:  2009-12-08       Impact factor: 66.675

Review 6.  Current development status of small-molecule vascular disrupting agents.

Authors:  David J Chaplin; Michael R Horsman; Dietmar W Siemann
Journal:  Curr Opin Investig Drugs       Date:  2006-06

7.  The discovery and mechanism of action of novel tumor-selective and apoptosis-inducing 3,5-diaryl-1,2,4-oxadiazole series using a chemical genetics approach.

Authors:  Katayoun A Jessen; Nicole M English; Jean Yu Wang; Sergei Maliartchouk; Shannon P Archer; Ling Qiu; Regina Brand; Jared Kuemmerle; Han-Zhong Zhang; Kurt Gehlsen; John Drewe; Ben Tseng; Sui Xiong Cai; Shailaja Kasibhatla
Journal:  Mol Cancer Ther       Date:  2005-05       Impact factor: 6.261

8.  Synthesis and antimicrobial activity of some novel oxadiazole derivatives.

Authors:  Mojahidul Islam; Anees A Siddiqui; Ramadoss Rajesh; Afroz Bakht; Sunil Goyal
Journal:  Acta Pol Pharm       Date:  2008 Jul-Aug       Impact factor: 0.330

9.  Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum.

Authors:  G R Pettit; S B Singh; M L Niven; E Hamel; J M Schmidt
Journal:  J Nat Prod       Date:  1987 Jan-Feb       Impact factor: 4.050

10.  A forward chemical screen using zebrafish embryos with novel 2-substituted 2H-chromene derivatives.

Authors:  Ingrid Torregroza; Todd Evans; Bhaskar C Das
Journal:  Chem Biol Drug Des       Date:  2009-03       Impact factor: 2.817

View more
  5 in total

1.  Synthesis of 2-(1,2,4-oxadiazol-3-yl)quinazolin-4(3H)-ones from diaminoglyoxime-based nitrones.

Authors:  Rahim Hosseinzadeh-Khanmiri; Abolghasem Moghimi; Ahmad Shaabani; Hassan Valizadeh; Seik Weng Ng
Journal:  Mol Divers       Date:  2015-04-22       Impact factor: 2.943

2.  Synthesis of a boron-containing amidoxime reagent and its application to synthesize functionalized oxadiazole and quinazolinone derivatives.

Authors:  Bhaskar C Das; Nitesh K Nandwana; Devi P Ojha; Sasmita Das; Todd Evans
Journal:  Tetrahedron Lett       Date:  2022-01-25       Impact factor: 2.032

Review 3.  Boron chemicals in diagnosis and therapeutics.

Authors:  Bhaskar C Das; Pritam Thapa; Radha Karki; Caroline Schinke; Sasmita Das; Suman Kambhampati; Sushanta K Banerjee; Peter Van Veldhuizen; Amit Verma; Louis M Weiss; Todd Evans
Journal:  Future Med Chem       Date:  2013-04       Impact factor: 3.808

4.  Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect.

Authors:  Tarek S Ibrahim; Mohamed M Hawwas; Azizah M Malebari; Ehab S Taher; Abdelsattar M Omar; Thikryat Neamatallah; Zakaria K Abdel-Samii; Martin K Safo; Yaseen A M M Elshaier
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

5.  A novel procedure for the synthesis of borylated quinolines and its application in the development of potential boron-based homeodomain interacting protein kinase 2 (HIPK2) inhibitors.

Authors:  Bhaskar C Das; Pratik Yadav; Sasmita Das; John Cijiang He
Journal:  RSC Adv       Date:  2022-08-25       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.